Skip to main content

Day: April 23, 2021

Johnson Outdoors to Release Fiscal 2021 Second Quarter Results on May 7, 2021

RACINE, Wis., April 23, 2021 (GLOBE NEWSWIRE) — JOHNSON OUTDOORS INC. (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, will release financial results for the Fiscal 2021 second quarter on Friday, May 7, 2021, before market open that day. The Company will host a conference call and audio webcast shortly afterwards at 11:00 a.m. Eastern Time to discuss the financial results and provide a Company update. A live listen-only webcast of the conference call may be accessed at Johnson Outdoors’ home page. A replay will be available on the Investor section home page on the Johnson Outdoors’ website – www.johnsonoutdoors.com – for 30 days. ABOUT JOHNSON OUTDOORS INC.JOHNSON OUTDOORS is a leading global outdoor recreation company that inspires more people to experience the awe of...

Continue reading

Southside Bancshares, Inc. Announces Financial Results for the First Quarter Ended March 31, 2021

Record first quarter net income of $34.1 million, an increase of 762.4%, compared to the same period in 2020; Annualized return on first quarter average assets of 1.99%; Annualized return on first quarter average tangible common equity of 21.22%(1); and Nonperforming assets decreased to 0.22% of total assets.TYLER, Texas, April 23, 2021 (GLOBE NEWSWIRE) — Southside Bancshares, Inc. (“Southside” or the “Company”) (NASDAQ: SBSI) today reported its financial results for the quarter ended March 31, 2021.  Southside reported net income of $34.1 million for the three months ended March 31, 2021, an increase of $30.1 million, or 762.4%, compared to $4.0 million for the same period in 2020.  Earnings per diluted common share increased $0.92, or 766.7%, to $1.04 for the three months ended March 31, 2021, from $0.12 for the same period...

Continue reading

Vistin Pharma ASA: Annual Report for 2020

Oslo, Norway, 23 April 2021 Please find attached the Annual Report for 2020 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year results presented on 19 February 2021. The annual report for 2020 will also be made available on www.vistin.com. ***** For further information, please contact: Alexander KarlsenCFO+47 97 05 36 21Alexander.karlsen@vistin.com   AttachmentsAnnual_Report_2020_Vistin_Pharma_ASA Signert beretning – Vistin Pharm ASA

Continue reading

Kvalitena ökar sitt ägande i Oscar Properties efter stor fastighetsaffär

Kvalitena AB (publ)(”Kvalitena”), har idag tecknat avtal med Oscar Properties Holding AB (publ) om att avyttra 16 fastigheter med ett underliggande fastighetsvärde om 930 miljoner kronor med ett årligt driftnetto uppgående till cirka 60 miljoner kronor. Förvärvet är villkorat av finansiering. Transaktionen gäller 16 fastigheter i Helsingborg, Skellefteå, Skövde, Sundsvall och Umeå med flera orter som tillsammans inrymmer en uthyrningsbar area om cirka 100 000 kvadratmeter. De tre största hyresgästerna står för 45 procent av hyresintäkterna och avtalen för dessa har en genomsnittlig löptid på 10,8 år. Totalt uppgår hyresvärdet till cirka 70 miljoner kronor årligen och merparten av hyresavtalen är så kallade triple net. Tillträde beräknas ske under det tredje kvartalet 2021. ”Med dessa förvärv fortsätter vi den resa vi påbörjat och utökar...

Continue reading

Green Hygienics Holdings Inc. Announces LOI for the Acquisition of Bohemian Beverage Co.

SAN DIEGO, April 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Green Hygienics Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”), a company focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, is very excited to announce it has entered into a letter of intent (the “LOI”) to acquire Bohemian Beverage Co. Bohemian Beverage Co. is a profitable, revenue-generating entity with an extraordinary brand portfolio of more than 20 unique beverage brands, including CBD-infused teas, ginger ale, beers, ciders, cocktails and more, which are directly distributed and sold through the company’s own subsidiary storefront. The company was also the very first brewery, cidery, distillery and manufacturer of...

Continue reading

Aequus Provides General Update and Reports Record 2020 Financial Results

VANCOUVER, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the year ended December 31, 2020 (“Fiscal 2020”) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. “We had a very strong end to our fiscal year and set new records for both the fourth quarter and annual revenue,” said Doug Janzen, Chairman and CEO of Aequus. “2020 gross revenues were $2,592,613 for the year, a 59% increase over Fiscal 2019 revenues of $1,632,524 and Q4 revenues were $851,187 a 59% increase over Q4 2019. Our fourth quarter is traditionally our strongest quarter, and we will...

Continue reading

Assisted Reproductive Technology Market Size 2021 | Is Projected to Reach USD 45.06 Billion by 2026, exhibiting a CAGR of 9.8% during Forecast 2019-2026

Pune, India, April 23, 2021 (GLOBE NEWSWIRE) — The Assisted Reproductive Technologies (ART) market size is projected to reach USD 45.06 billion by 2026, exhibiting a CAGR of 9.8% during the forecast period. The market was valued at USD 21.32 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Assisted Reproductive Technologies (ART) Market Size, Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026.” As per the report, increasing stress levels amongst the population is likely to result in the rising prevalence of infertility....

Continue reading

FINGRID GROUP – MANAGEMENT’S REVIEW 1 JANUARY – 31 MARCH 2021

Fingrid Oyj  Stock Exchange Release 23 April 2021 at 11:00 EET Fingrid Group – Management’s Review 1 January – 31 March 2021 Fingrid follows a six-month reporting period as referred to in the Securities Markets Act and publishes Management Reviews for the first three and nine months of the year; the Management Reviews contain key information illustrating the company’s financial and other development. The information presented in the Management’s Review relates to the Fingrid Group’s performance in January-March 2021 and the corresponding period of 2020, unless otherwise indicated. The figures presented here have been drawn up in accordance with International Financial Reporting Standards (IFRS). The Management’s Review is not an interim report in accordance with the IAS 34 standard. The figures are unaudited.The temperatures from...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.